CSL opens $1bn Australian vaccine and antivenom manufacturing facility
The Melbourne site adds Australia to a select group of…
The Melbourne site adds Australia to a select group of nations with advanced cell-based influenza vaccine capabilities.
List view / Grid view
The Melbourne site adds Australia to a select group of…
The Melbourne site adds Australia to a select group of nations with advanced cell-based influenza vaccine capabilities.
The Australian biotech's new operating model will also see medical…
The Australian biotech's new operating model will also see medical and commercial functions at its CSL Behring and CSL Vifor units combined.